Federal regulators have agreed to review a Swiss pharmaceutical company's applications for two cheaper generic versions of ...
Smart glasses come in more forms than most people realize. After reviewing more than 20 pairs, I'm breaking down what's out ...
The speakers discuss Netflix’s architecture for surviving extreme traffic spikes. They explain the mechanics of prioritized ...
Chatbots are far more predictable in their responses than you might expect. That's fine for research or coding, but it's a ...
Artificial intelligence has moved quickly from experimentation to real use inside the finance function. Controllers, chief accounting officers and CFOs are being asked to evaluate how AI can support ...
Save big with discount apps: Prescription discount apps like GoodRx, Cost Plus Drugs, and SingleCare can often beat your insurance price, saving consumers hundreds of dollars. Shop around before every ...
Reliable access to medicines has always mattered, but in today’s healthcare environment it has become a defining issue for pharmacy operations and patient care. Drug shortages, supply disruptions, and ...
The US Supreme Court ruled yesterday, June 4, that pharmaceutical company Hikma’s generic cardiovascular drug does not infringe global biopharmaceutical company Amarin’s patents covering its drug ...
In recent weeks, Canada became the first G7 country to approve a generic version of the popular drug Ozempic. Elizabeth Doran has been taking GLP-1 medications for nearly a year for weight loss to ...
Dr. Ouyang is an emergency physician and an associate professor at Columbia. Several months ago, I got the results back from some routine blood tests, and let’s just say several numbers were a tad too ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results